Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models

Overview of attention for article published in BMC Cancer, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

reddit: 1 Redditor

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Reddit Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

PHARMACEUTICAL COMBINATION OF FAK INHIBITOR AND EGFR-TKI, AND USE

Application WO-2024051679-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.